Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Vishal Chandra"'
Autor:
Vishal Chandra Sharma, Sudha Vidyasagar, Cynthia Amrutha Sukumar, Nanda Krishna B, Sharanya Shree
Publikováno v:
BMC Endocrine Disorders, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background The past few decades have seen a marked increase in the macrovascular complications of Type-2 diabetes mellitus (T2DM) such as coronary heart disease, peripheral arterial disease, and cerebrovascular disease. This has been predomi
Externí odkaz:
https://doaj.org/article/483a4bdad6ca44e69eafdee9e8eef21c
Autor:
Zheng Han, William M. MacCuaig, Metin N. Gurcan, Juan Claros-Sorto, Tabitha Garwe, Christina Henson, Jennifer Holter-Chakrabarty, Bethany Hannafon, Vishal Chandra, Elizabeth Wellberg, Lacey R. McNally
Publikováno v:
Photoacoustics, Vol 32, Iss , Pp 100531- (2023)
Clinical tools for measuring tumor vascular hemodynamics, such as dynamic contrast-enhanced MRI, are clinically important to assess tumor properties. Here we explored the use of multispectral optoacoustic tomography (MSOT), which has a high spatial a
Externí odkaz:
https://doaj.org/article/ad26c02137cb4a2584c37990fbc63ffb
Autor:
Vishal Chandra Sharma, Sudha Vidyasagar, Cynthia Amrutha Sukumar, Nanda Krishna B, Sharanya Shree
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/8345a860087f40a8ad4dad8172f857f6
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 161, Iss , Pp 114422- (2023)
Endometrial cancer is the most common female cancer showing continuous rise in its incidence and mortality rate. Despite the extensive research efforts in cancer therapeutics, still there is a lack of effective treatment options and the outcome is po
Externí odkaz:
https://doaj.org/article/80fad4d5605e463a86804c4f6164ef64
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Drug-targetable vulnerabilities of cancer cells include their dependence on heat shock proteins (HSPs) to support elevated mitochondrial metabolism and counteract cell death factors. The investigational new drug SHetA2 targets these vulnerabilities i
Externí odkaz:
https://doaj.org/article/c92c8f79e0b247c487b8350f0c10ec09
Publikováno v:
Pesquisa Brasileira em Odontopediatria e Clínica Integrada, Vol 22 (2022)
Objective: To quantify and compare respiratory functions and further screen the oral mucosa of tobacco and non-tobacco users. Material and Methods: First control group, non-tobacco users (n=55); Second group, smokers’ group (n=168) who currently sm
Externí odkaz:
https://doaj.org/article/64d35c6d45fb4852b741af86c86ee326
Autor:
Han-Seong Kim, Jae-Soo Koh, Yong-Bock Choi, Jungsil Ro, Hyun-Kyoung Kim, Mi-Kyung Kim, Byung-Ho Nam, Kyung-Tae Kim, Vishal Chandra, Hye-Sil Seol, Woo-Chul Noh, Eun-Kyu Kim, Joobae Park, Chang-Dae Bae, Kyeong-Man Hong
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98160 (2014)
BACKGROUND: The level of proliferation activity is a strong prognostic or predictive indicator in breast cancer, but its optimal measurement is still in debate, necessitating new proliferation markers. In the present study, the prognostic significanc
Externí odkaz:
https://doaj.org/article/ffcfe40a5d494da9aca625e9dbaff19c
Autor:
Hyun-Kyoung Kim, Won Cheol Park, Kwang Man Lee, Hai-Li Hwang, Seong-Yeol Park, Sungbin Sorn, Vishal Chandra, Kwang Gi Kim, Woong-Bae Yoon, Joon Seol Bae, Hyoung Doo Shin, Jong-Yeon Shin, Ju-Young Seoh, Jong-Il Kim, Kyeong-Man Hong
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100089 (2014)
BACKGROUND: The concept of the utilization of rearranged ends for development of personalized biomarkers has attracted much attention owing to its clinical applicability. Although targeted next-generation sequencing (NGS) for recurrent rearrangements
Externí odkaz:
https://doaj.org/article/894c19448b494c81b9cc3beda0c3fd0a
Autor:
Ruchi Saxena, Vishal Chandra, Murli Manohar, Kanchan Hajela, Utsab Debnath, Yenamandra S Prabhakar, Karan Singh Saini, Rituraj Konwar, Sandeep Kumar, Kaling Megu, Bal Gangadhar Roy, Anila Dwivedi
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e66246 (2013)
Inhibition of epidermal growth factor receptor (EGFR) signaling is considered to be a promising treatment strategy for estrogen receptor (ER)-negative breast tumors. We have investigated here the anti-breast cancer properties of a novel anti-prolifer
Externí odkaz:
https://doaj.org/article/6857c3de7aa34bcc9c0118c41f4072ec
Autor:
Sharma, Vishal Chandra1 (AUTHOR), Vidyasagar, Sudha1 (AUTHOR), Sukumar, Cynthia Amrutha1 (AUTHOR) cynthiaamrutha@gmail.com, Krishna B, Nanda1 (AUTHOR), Shree, Sharanya2 (AUTHOR)
Publikováno v:
BMC Endocrine Disorders. 12/6/2023, Vol. 23 Issue 1, p1-8. 8p.